AstraZeneca tixagevimab, cilgavimab cocktail shows positive result in Covid-19 trial MD Bureau12 Oct 2021 10:00 AM ISTLondon: AstraZeneca's long-acting antibody combination is both able to prevent and treat Covid-19, according to the phase three results released on...
USFDA grants Orphan Drug Designation to AstraZeneca Tezepelumab Ruchika Sharma11 Oct 2021 1:04 PM ISTUK: AstraZeneca has announced that Tezepelumab has been granted Orphan Drug Designation (ODD) in the US by the Food and Drug Administration (FDA) for...
AstraZeneca seeks USFDA authorization for Covid-19 Prophylaxis drug AZD7442 Ruchika Sharma6 Oct 2021 2:13 PM ISTUK: AstraZeneca has submitted a request to the US Food and Drug Administration (USFDA) for an Emergency Use Authorization (EUA) for AZD7442, its...
AstraZeneca India, healthtech startup Tricog launch project to reduce heart failure Ruchika Sharma29 Sept 2021 12:00 PM ISTMumbai: AstraZeneca India, a biopharmaceutical company, together with health-tech startup, Tricog, has rolled out a programme called...
AstraZeneca Pharma India bags DCGI nod to import and market Selumetinib capsules Ruchika Sharma27 Sept 2021 4:02 PM ISTNew Delhi: Drugmaker, AstraZeneca Pharma India Limited, has recently announced that the company has received import and market permission in Form...
India may allow to minimise gap between Covishield doses sold privately: Report Ruchika Sharma24 Sept 2021 10:45 AM ISTNew Delhi: India is likely to allow a smaller gap between AstraZeneca COVID-19 vaccine doses for inoculations being carried out privately, in line...
No quarantine relief for Indians despite UK nod to Covishield as qualified vaccine Ruchika Sharma23 Sept 2021 2:00 PM ISTNew Delhi: Indian travellers vaccinated with two doses of Covishield will still have to undergo 10 days of quarantine in the UK even as the vaccine...
New brand names authorized for 3 Covid-19 vaccines in Canada, Details Medical Dialogues Team17 Sept 2021 2:18 PM ISTNew Delhi: Three approved Covid-19 vaccines manufacture by Pfizer-BioNTech , Moderna, and AstraZeneca will now be called Comirnaty, SpikeVax, and...
EMA lists nerve disorder as side effect of AstraZeneca COVID vaccine MD Bureau11 Sept 2021 10:15 AM ISTAmsterdam: The European health regulatory body has listed Guillain-Barre Syndrome (GBS) -- a neurological disorder -- as a "very rare" side effect of...
Booster doses of Pfizer, AstraZeneca COVID vaccines approved in UK MD Bureau10 Sept 2021 12:37 PM ISTLondon: The UK's health regulator has approved Pfizer and AstraZeneca vaccines for booster doses against Covid-19, even as the country's decision on...
COVID-19 vaccines effective in obese people: A position statement from Obesity Society Hina Zahid8 Sept 2021 12:15 AM ISTTOS encourages individuals with obesity to undergo vaccination with any of the available vaccines authorized for emergency use by the U.S. Food and...
AstraZeneca gets nod for CKD, type 2 diabetes treatment Forxiga in Japan Ruchika Sharma29 Aug 2021 10:15 AM ISTUK: AstraZeneca has recently announced that Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in...
